|
一、中文期刊
楊采菱 (2005) 政令宣導 全國微生物抗藥性監測計畫 (Taiwan Surveillance of Antimicrobial Resistance; TSAR). 感染控制雜誌 15, 313-318.
楊采菱、洪哲倫及印筱娟 (2006) 疾病管制局專欄 台灣地區 1997-2003 年住院病人抗生素使用報告. 感染控制雜誌 16, 299-303.
二、西文圖書
CLSI (2009) Performance standards for antimicrobial susceptibility testing. Nineteen informational supplement. M100-S19.: Wayne (PA): Clinical and Laboratory Standards Institute.
CLSI (2010) Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. M100-S20.: Wayne (PA): Clinical and Laboratory Standards Institute.
Donnenberg, M.S. (2014) Enterobacteriaceae. In: Bennett, J.E., Dolin, R. and Blaser, M.J. ed. Mandell, Douglas, and Bennett's principles and practice of infectious diseases: Elsevier Health Sciences; p 2503-2517.
Paniker, A.A., Ananthanarayan, R. and Paniker, C.K.J. (2005) Enterobacteriaceae I: Coliforms - Proteus. In: Ananthanarayan and Paniker's Textbook of Microbiology: Orient Longman. p 271-284.
三、西文期刊
Abraham, E.P. and Chain, E. (1988) An enzyme from bacteria able to destroy penicillin. 1940. Rev Infect Dis 10, 677-678.
Acar, J.F., Goldstein, F. and Chabbert, Y.A. (1973) Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo. J Infect Dis 128, Suppl:470-477.
Afset, J.E., Bevanger, L., Romundstad, P. and Bergh, K. (2004) Association of atypical enteropathogenic Escherichia coli (EPEC) with prolonged diarrhoea. J Med Microbiol 53, 1137-1144.
Al-Hasan, M.N., Lahr, B.D., Eckel-Passow, J.E. and Baddour, L.M. (2009) Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother 64, 169-174.
Al-Majali, A.M., Asem, E.K., Lamar, C.H., Robinson, J.P., Freeman, M.J. and Saeed, A.M. (2000) Characterization of the interaction of Escherichia coli heat-stable enterotoxin (STa) with its putative receptor on the intestinal tract of newborn calves. FEMS Immunol Med Microbiol 28, 97-104.
Aldeyab, M.A., Harbarth, S., Vernaz, N., Kearney, M.P., Scott, M.G., Darwish Elhajji, F.W., Aldiab, M.A. and McElnay, J.C. (2012) The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol 74, 171-179.
Allen, N.E., Hobbs, J.N. and Alborn, W.E., Jr. (1987) Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032. Antimicrob Agents Chemother 31, 1093-1099.
Ambler, R.P. (1980) The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci 289, 321-331.
Apisarnthanarak, A., Bailey, T.C. and Fraser, V.J. (2008) Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 46, 1322-1323.
Ashkar, A.A., Mossman, K.L., Coombes, B.K., Gyles, C.L. and Mackenzie, R. (2008) FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog 4, e1000233.
Babic, M., Hujer, A.M. and Bonomo, R.A. (2006) What's new in antibiotic resistance? Focus on beta-lactamases. Drug Resist Updat 9, 142-156.
Bauer, M.E. and Welch, R.A. (1996) Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7. Infect Immun 64, 167-175.
Bell, B.P., Goldoft, M., Griffin, P.M., Davis, M.A., Gordon, D.C., Tarr, P.I., Bartleson, C.A., Lewis, J.H., Barrett, T.J., Wells, J.G. and et al. (1994) A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA 272, 1349-1353.
Belland, R.J., Morrison, S.G., Ison, C. and Huang, W.M. (1994) Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol 14, 371-380.
Ben-Ami, R., Schwaber, M.J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A. and Carmeli, Y. (2006) Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42, 925-934.
Bennett A. R., MacPhee S., Betts R. P.(1995) Evaluation of methods for the isolation and detection of Escherichia coli O157 in minced beef. Lett Appl Microbiol 20, 375–379.
Bhan, M.K., Khoshoo, V., Sommerfelt, H., Raj, P., Sazawal, S. and Srivastava, R. (1989a) Enteroaggregative Escherichia coli and Salmonella associated with nondysenteric persistent diarrhea. Pediatr Infect Dis J 8, 499-502.
Bhan, M.K., Raj, P., Levine, M.M., Kaper, J.B., Bhandari, N., Srivastava, R., Kumar, R. and Sazawal, S. (1989b) Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. J Infect Dis 159, 1061-1064.
Bilge, S.S., Clausen, C.R., Lau, W. and Moseley, S.L. (1989) Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells. J Bacteriol 171, 4281-4289.
Bisson, G., Fishman, N.O., Patel, J.B., Edelstein, P.H. and Lautenbach, E. (2002) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 23, 254-260.
Black, J.A., Moland, E.S. and Thomson, K.S. (2005) AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. J Clin Microbiol 43, 3110-3113.
Blake, P.A., Ramos, S., MacDonald, K.L., Rassi, V., Gomes, T.A., Ivey, C., Bean, N.H. and Trabulsi, L.R. (1993) Pathogen-specific risk factors and protective factors for acute diarrheal disease in urban Brazilian infants. J Infect Dis 167, 627-632.
Blanco, J., Mora, A., Mamani, R., Lopez, C., Blanco, M., Dahbi, G., Herrera, A., Blanco, J.E., Alonso, M.P., Garcia-Garrote, F., Chaves, F., Orellana, M.A., Martinez-Martinez, L., Calvo, J., Prats, G., Larrosa, M.N., Gonzalez-Lopez, J.J., Lopez-Cerero, L., Rodriguez-Bano, J. and Pascual, A. (2011) National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J Antimicrob Chemother 66, 2011-2021.
Bloch, C.A., Stocker, B.A. and Orndorff, P.E. (1992) A key role for type 1 pili in enterobacterial communicability. Mol Microbiol 6, 697-701.
Bolhuis, H., van Veen, H.W., Brands, J.R., Putman, M., Poolman, B., Driessen, A.J. and Konings, W.N. (1996) Energetics and mechanism of drug transport mediated by the lactococcal multidrug transporter LmrP. J Biol Chem 271, 24123-24128.
Bradford, P.A. (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14, 933-951.
Bray, J. (1945) Isolation of antigenically homogeneous strains of Bact. coli neapolitanum from summer diarrhoea of infants. J Pathol Bacteriol 57, 239-247.
Bugg, T.D. and Walsh, C.T. (1992) Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: enzymology, antibiotics, and antibiotic resistance. Nat Prod Rep 9, 199-215.
Bush, K. (2012) Antimicrobial agents targeting bacterial cell walls and cell membranes. Rev Sci Tech 31, 43-56.
Bush, K., Jacoby, G.A. and Medeiros, A.A. (1995) A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39, 1211-1233.
Camara, L.M., Carbonare, S.B., Silva, M.L. and Carneiro-Sampaio, M.M. (1994) Inhibition of enteropathogenic Escherichia coli (EPEC) adhesion to HeLa cells by human colostrum: detection of specific sIgA related to EPEC outer-membrane proteins. Int Arch Allergy Immunol 103, 307-310.
Campbell, E.A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A. and Darst, S.A. (2001) Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 104, 901-912.
Canton, R. and Coque, T.M. (2006) The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9, 466-475.
Carbonetti, N.H., Boonchai, S., Parry, S.H., Vaisanen-Rhen, V., Korhonen, T.K. and Williams, P.H. (1986) Aerobactin-mediated iron uptake by Escherichia coli isolates from human extraintestinal infections. Infect Immun 51, 966-968.
Chambers, H.F. (1997) Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10, 781-791.
Chandler, W.L., Jelacic, S., Boster, D.R., Ciol, M.A., Williams, G.D., Watkins, S.L., Igarashi, T. and Tarr, P.I. (2002) Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 346, 23-32.
Chen, C.M., Ke, S.C., Li, C.R., Chiou, C.S. and Chang, C.C. (2014) Prolonged Clonal Spreading and Dynamic Changes in Antimicrobial Resistance of Escherichia coli ST68 Among Patients Who Stayed in a Respiratory Care Ward. J Med Microbiol 63, 1531-1541.
Chen, C.R., Malik, M., Snyder, M. and Drlica, K. (1996) DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J Mol Biol 258, 627-637.
Chopra, I. and Roberts, M. (2001) Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65, 232-260.
Chow, J.W., Fine, M.J., Shlaes, D.M., Quinn, J.P., Hooper, D.C., Johnson, M.P., Ramphal, R., Wagener, M.M., Miyashiro, D.K. and Yu, V.L. (1991) Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115, 585-590.
Chung, H.C., Lai, C.H., Lin, J.N., Huang, C.K., Liang, S.H., Chen, W.F., Shih, Y.C., Lin, H.H. and Wang, J.L. (2012) Bacteremia caused by extended-spectrum-beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 56, 618-622.
Clancy, J., Petitpas, J., Dib-Hajj, F., Yuan, W., Cronan, M., Kamath, A.V., Bergeron, J. and Retsema, J.A. (1996) Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol 22, 867-879.
Cohen, M.B., Nataro, J.P., Bernstein, D.I., Hawkins, J., Roberts, N. and Staat, M.A. (2005) Prevalence of diarrheagenic Escherichia coli in acute childhood enteritis: a prospective controlled study. J Pediatr 146, 54-61.
Coimbra, R.S., Grimont, F., Lenormand, P., Burguiere, P., Beutin, L. and Grimont, P.A. (2000) Identification of Escherichia coli O-serogroups by restriction of the amplified O-antigen gene cluster (rfb-RFLP). Res Microbiol 151, 639-654.
Connell, I., Agace, W., Klemm, P., Schembri, M., Marild, S. and Svanborg, C. (1996) Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 93, 9827-9832.
Cornelis, G.R. (2006) The type III secretion injectisome. Nat Rev Microbiol 4, 811-825.
Cravioto, A., Gross, R., Scotland, S. and Rowe, B. (1979) An adhesive factor found in strains of Escherichia coli belonging to the traditional infantile enteropathogenic serotypes. Curr Microbiol 3, 95-99.
Cravioto, A., Tello, A., Navarro, A., Ruiz, J., Villafan, H., Uribe, F. and Eslava, C. (1991a) Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea. Lancet 337, 262-264.
Cravioto, A., Tello, A., Villafan, H., Ruiz, J., del Vedovo, S. and Neeser, J.R. (1991b) Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J Infect Dis 163, 1247-1255.
Cross, A.S., Kim, K.S., Wright, D.C., Sadoff, J.C. and Gemski, P. (1986) Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli. J Infect Dis 154, 497-503.
Crump, J.A., Sulka, A.C., Langer, A.J., Schaben, C., Crielly, A.S., Gage, R., Baysinger, M., Moll, M., Withers, G., Toney, D.M., Hunter, S.B., Hoekstra, R.M., Wong, S.K., Griffin, P.M. and Van Gilder, T.J. (2002) An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. N Engl J Med 347, 555-560.
Cuzon, G., Ouanich, J., Gondret, R., Naas, T. and Nordmann, P. (2011) Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 55, 2420-2423.
D'Haeze, W. (2002) Secreting an enterotoxin. Genome Biol 3, reports0049.
Datta, N. and Kontomichalou, P. (1965) Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature 208, 239-241.
Datta, S., Wattal, C., Goel, N., Oberoi, J.K., Raveendran, R. and Prasad, K.J. (2012) A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli & Klebsiella pneumoniae in a tertiary care hospital. Indian J Med Res 135, 907-912.
De La Cochetiere, M.F., Durand, T., Lepage, P., Bourreille, A., Galmiche, J.P. and Dore, J. (2005) Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43, 5588-5592.
Delcour, A.H. (2009) Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 1794, 808-816.
Denis, C., Poirel, L., Carricajo, A., Grattard, F., Fascia, P., Verhoeven, P., Gay, P., Nuti, C., Nordmann, P., Pozzetto, B. and Berthelot, P. (2012) Nosocomial transmission of NDM-1-producing Escherichia coli within a non-endemic area in France. Clin Microbiol Infect 18, E128-130.
Dinubile, M.J., Friedland, I., Chan, C.Y., Motyl, M.R., Giezek, H., Shivaprakash, M., Weinstein, R.A. and Quinn, J.P. (2005) Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis 24, 443-449.
Donskey, C.J. (2004) The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 39, 219-226.
Donskey, C.J. (2006) Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli. Clin Infect Dis 43 Suppl 2, S62-69.
Drlica, K., Malik, M., Kerns, R.J. and Zhao, X. (2008) Quinolone-mediated bacterial death. Antimicrob Agents Chemother 52, 385-392.
Drlica, K. and Zhao, X. (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61, 377-392.
DuPont, H.L., Formal, S.B., Hornick, R.B., Snyder, M.J., Libonati, J.P., Sheahan, D.G., LaBrec, E.H. and Kalas, J.P. (1971) Pathogenesis of Escherichia coli diarrhea. N Engl J Med 285, 1-9.
Durrer, P., Zbinden, R., Fleisch, F., Altwegg, M., Ledergerber, B., Karch, H. and Weber, R. (2000) Intestinal infection due to enteroaggregative Escherichia coli among human immunodeficiency virus-infected persons. J Infect Dis 182, 1540-1544.
Economou, A., Christie, P.J., Fernandez, R.C., Palmer, T., Plano, G.V. and Pugsley, A.P. (2006) Secretion by numbers: Protein traffic in prokaryotes. Mol Microbiol 62, 308-319.
Elsinghorst, E.A. and Weitz, J.A. (1994) Epithelial cell invasion and adherence directed by the enterotoxigenic Escherichia coli tib locus is associated with a 104-kilodalton outer membrane protein. Infect Immun 62, 3463-3471.
Ericsson, C.D. and DuPont, H.L. (1993) Travelers' diarrhea: approaches to prevention and treatment. Clin Infect Dis 16, 616-624.
Escolar, L., Perez-Martin, J. and de Lorenzo, V. (1999) Opening the iron box: transcriptional metalloregulation by the Fur protein. J Bacteriol 181, 6223-6229.
Falagas, M.E., Rafailidis, P.I. and Matthaiou, D.K. (2010) Resistance to polymyxins: Mechanisms, frequency and treatment options. Drug Resist Updat 13, 132-138.
Falkow, S. (1988) Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 10, S274-S276.
Farmer, J.J., 3rd and Davis, B.R. (1985) H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol 22, 620-625.
Fath, M.J. and Kolter, R. (1993) ABC transporters: bacterial exporters. Microbiol Rev 57, 995-1017.
Fleckenstein, J.M., Lindler, L.E., Elsinghorst, E.A. and Dale, J.B. (2000) Identification of a gene within a pathogenicity island of enterotoxigenic Escherichia coli H10407 required for maximal secretion of the heat-labile enterotoxin. Infect Immun 68, 2766-2774.
Foreman, D.T., Martinez, Y., Coombs, G., Torres, A. and Kupersztoch, Y.M. (1995) TolC and DsbA are needed for the secretion of STB, a heat-stable enterotoxin of Escherichia coli. Mol Microbiol 18, 237-245.
Fratamico, P.M., Buchanan, R.L. and Cooke, P.H. (1993) Virulence of an Escherichia coli O157:H7 sorbitol-positive mutant. Appl Environ Microbiol 59, 4245-4252.
Galan, J.E. and Collmer, A. (1999) Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284, 1322-1328.
Garner, J.S., Jarvis, W.R., Emori, T.G., Horan, T.C. and Hughes, J.M. (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16, 128-140.
Gassama-Sow, A., Sow, P.S., Gueye, M., Gueye-N'diaye, A., Perret, J.L., M'Boup, S. and Aidara-Kane, A. (2004) Characterization of pathogenic Escherichia coli in human immunodeficiency virus-related diarrhea in Senegal. J Infect Dis 189, 75-78.
Gellert, M., Mizuuchi, K., O'Dea, M.H. and Nash, H.A. (1976) DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci U S A 73, 3872-3876.
Giron, J.A., Donnenberg, M.S., Martin, W.C., Jarvis, K.G. and Kaper, J.B. (1993) Distribution of the bundle-forming pilus structural gene (bfpA) among enteropathogenic Escherichia coli. J Infect Dis 168, 1037-1041.
Glandt, M., Adachi, J.A., Mathewson, J.J., Jiang, Z.D., DiCesare, D., Ashley, D., Ericsson, C.D. and DuPont, H.L. (1999) Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. Clin Infect Dis 29, 335-338.
Glaser, R., Harder, J., Lange, H., Bartels, J., Christophers, E. and Schroder, J.M. (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6, 57-64.
Gold, H.S. and Moellering, R.C., Jr. (1996) Antimicrobial-drug resistance. N Engl J Med 335, 1445-1453.
Griffin, P.M., Ostroff, S.M., Tauxe, R.V., Greene, K.D., Wells, J.G., Lewis, J.H. and Blake, P.A. (1988) Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med 109, 705-712.
Grinius, L., Dreguniene, G., Goldberg, E.B., Liao, C.H. and Projan, S.J. (1992) A staphylococcal multidrug resistance gene product is a member of a new protein family. Plasmid 27, 119-129.
Gross, R.J., Ward, L.R., Threlfall, E.J., Cheasty, T. and Rowe, B. (1983) Drug resistance among Escherichia coli strains isolated from cerebrospinal fluid. J Hyg (Lond) 90, 195-198.
Han, J.H., Kasahara, K., Edelstein, P.H., Bilker, W.B. and Lautenbach, E. (2012a) Risk factors for infection or colonization with CTX-M extended-spectrum-beta-lactamase-positive Escherichia coli. Antimicrob Agents Chemother 56, 5575-5580.
Han, J.H., Nachamkin, I., Zaoutis, T.E., Coffin, S.E., Linkin, D.R., Fishman, N.O., Weiner, M.G., Hu, B., Tolomeo, P. and Lautenbach, E. (2012b) Risk factors for gastrointestinal tract colonization with extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients. Infect Control Hosp Epidemiol 33, 1242-1245.
Hansen, L.H., Johannesen, E., Burmolle, M., Sorensen, A.H. and Sorensen, S.J. (2004) Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother 48, 3332-3337.
Harris, A.D., Kotetishvili, M., Shurland, S., Johnson, J.A., Morris, J.G., Nemoy, L.L. and Johnson, J.K. (2007a) How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Control 35, 97-101.
Harris, A.D., McGregor, J.C., Johnson, J.A., Strauss, S.M., Moore, A.C., Standiford, H.C., Hebden, J.N. and Morris, J.G., Jr. (2007b) Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 13, 1144-1149.
Hartmann, G., Honikel, K.O., Knusel, F. and Nuesch, J. (1967) The specific inhibition of the DNA-directed RNA synthesis by rifamycin. Biochim Biophys Acta 145, 843-844.
Hawkey, P.M. and Jones, A.M. (2009) The changing epidemiology of resistance. J Antimicrob Chemother 64 Suppl 1, i3-10.
Henderson, I.R. and Nataro, J.P. (2001) Virulence functions of autotransporter proteins. Infect Immun 69, 1231-1243.
Higgins, C.F. (1992) ABC transporters: from microorganisms to man. Annu Rev Cell Biol 8, 67-113.
Hilty, M., Betsch, B.Y., Bogli-Stuber, K., Heiniger, N., Stadler, M., Kuffer, M., Kronenberg, A., Rohrer, C., Aebi, S., Endimiani, A., Droz, S. and Muhlemann, K. (2012) Transmission Dynamics of Extended-Spectrum beta-lactamase-Producing Enterobacteriaceae in the Tertiary Care Hospital and the Household Setting. Clin Infect Dis 55, 967-975.
Hoffman, J.A., Wass, C., Stins, M.F. and Kim, K.S. (1999) The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier. Infect Immun 67, 3566-3570.
Holtje, J.V. (1998) Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli. Microbiol Mol Biol Rev 62, 181-203.
Horwitz, M.A. and Silverstein, S.C. (1980) Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest 65, 82-94.
Hsueh, P.R., Badal, R.E., Hawser, S.P., Hoban, D.J., Bouchillon, S.K., Ni, Y., Paterson, D.L. and Asia-Pacific, S.G. (2010) Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int J Antimicrob Agents 36, 408-414.
Huang, C.C., Chen, Y.S., Toh, H.S., Lee, Y.L., Liu, Y.M., Ho, C.M., Lu, P.L., Liu, C.E., Chen, Y.H., Wang, J.H., Tang, H.J., Yu, K.W., Liu, Y.C., Chuang, Y.C., Xu, Y., Ni, Y., Ko, W.C. and Hsueh, P.R. (2012) Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010. Int J Antimicrob Agents 40 Suppl, S4-10.
Humeniuk, C., Arlet, G., Gautier, V., Grimont, P., Labia, R. and Philippon, A. (2002) Beta-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob Agents Chemother 46, 3045-3049.
Hung, C.S., Bouckaert, J., Hung, D., Pinkner, J., Widberg, C., DeFusco, A., Auguste, C.G., Strouse, R., Langermann, S., Waksman, G. and Hultgren, S.J. (2002) Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol 44, 903-915.
Ironmonger, D., Edeghere, O., Bains, A., Loy, R., Woodford, N. and Hawkey, P.M. (2015) Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years. J Antimicrob Chemother 70, 1744-1750.
Jacoby, G.A. and Munoz-Price, L.S. (2005) The new beta-lactamases. N Engl J Med 352, 380-391.
Jay, M.T., Cooley, M., Carychao, D., Wiscomb, G.W., Sweitzer, R.A., Crawford-Miksza, L., Farrar, J.A., Lau, D.K., O'Connell, J., Millington, A., Asmundson, R.V., Atwill, E.R. and Mandrell, R.E. (2007) Escherichia coli O157:H7 in feral swine near spinach fields and cattle, central California coast. Emerg Infect Dis 13, 1908-1911.
Jernberg, C., Lofmark, S., Edlund, C. and Jansson, J.K. (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1, 56-66.
Johnson, J.R. (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4, 80-128.
Johnson, J.R., Moseley, S.L., Roberts, P.L. and Stamm, W.E. (1988) Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 56, 405-412.
Johnson, T.J. and Nolan, L.K. (2009) Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev 73, 750-774.
Jones, R.N. (1998) Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes. Diagn Microbiol Infect Dis 31, 461-466.
Kang, C.I., Wi, Y.M., Lee, M.Y., Ko, K.S., Chung, D.R., Peck, K.R., Lee, N.Y. and Song, J.H. (2012) Epidemiology and risk factors of community onset infections caused by extended-spectrum beta-lactamase-producing Escherichia coli strains. J Clin Microbiol 50, 312-317.
Kaper, J. (1996) Defining EPEC. Revista de Microbiologia 27, 130-133.
Kaper, J.B., Nataro, J.P. and Mobley, H.L. (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2, 123-140.
Kim, K.S. (2002) Strategy of Escherichia coli for crossing the blood-brain barrier. J Infect Dis 186 Suppl 2, S220-224.
Kliebe, C., Nies, B.A., Meyer, J.F., Tolxdorff-Neutzling, R.M. and Wiedemann, B. (1985) Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 28, 302-307.
Kohanski, M.A., DePristo, M.A. and Collins, J.J. (2010a) Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 37, 311-320.
Kohanski, M.A., Dwyer, D.J. and Collins, J.J. (2010b) How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 8, 423-435.
Korhonen, T.K., Valtonen, M.V., Parkkinen, J., Vaisanen-Rhen, V., Finne, J., Orskov, F., Orskov, I., Svenson, S.B. and Makela, P.H. (1985) Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun 48, 486-491.
Kronvall, G. (2010) Antimicrobial resistance 1979-2009 at Karolinska hospital, Sweden: normalized resistance interpretation during a 30-year follow-up on Staphylococcus aureus and Escherichia coli resistance development. APMIS 118, 621-639.
Kumar, A. and Schweizer, H.P. (2005) Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 57, 1486-1513.
Kuo, L.C., Yu, C.J., Kuo, M.L., Chen, W.N., Chang, C.K., Lin, H.I., Chen, C.C., Lu, M.C., Lin, C.H., Hsieh, W.F., Chen, L.W., Chou, Y., Huang, M.S., Lee, C.H., Chen, S.C., Thai, S.L., Chen, P.C., Chen, C.H., Tseng, C.C., Chen, Y.S., Hsiue, T.R. and Hsueh, P.R. (2008) Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study. Int J Antimicrob Agents 31, 420-426.
Kuster, S.P., Hasse, B., Huebner, V., Bansal, V., Zbinden, R., Ruef, C., Ledergerber, B. and Weber, R. (2010) Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection 38, 33-40.
Kwa, A., Kasiakou, S.K., Tam, V.H. and Falagas, M.E. (2007) Polymyxin B: similarities to and differences from colistin (polymyxin E). Expert Rev Anti Infect Ther 5, 811-821.
Lambert, P.A. (2005) Bacterial resistance to antibiotics: modified target sites. Adv Drug Deliv Rev 57, 1471-1485.
Landman, D., Bratu, S., Kochar, S., Panwar, M., Trehan, M., Doymaz, M. and Quale, J. (2007) Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother 60, 78-82.
Lathem, W.W., Grys, T.E., Witowski, S.E., Torres, A.G., Kaper, J.B., Tarr, P.I. and Welch, R.A. (2002) StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol Microbiol 45, 277-288.
Lautenbach, E., Patel, J.B., Bilker, W.B., Edelstein, P.H. and Fishman, N.O. (2001a) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32, 1162-1171.
Lautenbach, E., Strom, B.L., Bilker, W.B., Patel, J.B., Edelstein, P.H. and Fishman, N.O. (2001b) Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 33, 1288-1294.
Lavigne, J.P., Marchandin, H., Delmas, J., Bouziges, N., Lecaillon, E., Cavalie, L., Jean-Pierre, H., Bonnet, R. and Sotto, A. (2006) qnrA in CTX-M-producing Escherichia coli isolates from France. Antimicrob Agents Chemother 50, 4224-4228.
Leclercq, R. (2002) Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 34, 482-492.
Lee, Y.L., Chen, Y.S., Toh, H.S., Huang, C.C., Liu, Y.M., Ho, C.M., Lu, P.L., Ko, W.C., Chen, Y.H., Wang, J.H., Tang, H.J., Yu, K.W., Liu, Y.C., Chuang, Y.C., Liu, C.E. and Hsueh, P.R. (2012) Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010. Int J Antimicrob Agents 40 Suppl, S29-36.
Leflon-Guibout, V., Speldooren, V., Heym, B. and Nicolas-Chanoine, M. (2000) Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes. Antimicrob Agents Chemother 44, 2709-2714.
Leverstein-van Hall, M.A., HE, M.B., AR, T.D., Paauw, A., Fluit, A.C. and Verhoef, J. (2003) Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. J Infect Dis 187, 251-259.
Levine, M.M., Nataro, J.P., Karch, H., Baldini, M.M., Kaper, J.B., Black, R.E., Clements, M.L. and O'Brien, A.D. (1985) The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis 152, 550-559.
Li, X.Z. and Nikaido, H. (2009) Efflux-mediated drug resistance in bacteria: an update. Drugs 69, 1555-1623.
Lim, Y.S., Ngan, C.C. and Tay, L. (1992) Enteropathogenic Escherichia coli as a cause of diarrhoea among children in Singapore. J Trop Med Hyg 95, 339-342.
Lin, C.J., Siu, L.K., Ma, L., Chang, Y.T. and Lu, P.L. (2012) Molecular epidemiology of ciprofloxacin-resistant extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Taiwan. Microb Drug Resist 18, 52-58.
Liu, K.S., Wang, Y.T., Lai, Y.C., Yu, S.F., Huang, S.J., Huang, H.J., Lu, M.C. and Hsueh, P.R. (2011) Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study comparison of the characteristics of nosocomial infection and antimicrobial-resistant bacteria in adult Intensive Care Units and two respiratory care facilities for mechanically ventilated patients at a tertiary care centre in Taiwan. Int J Antimicrob Agents 37, 10-15.
Liu, P.Y., Lau, Y.J., Hu, B.S., Shyr, J.M., Shi, Z.Y., Tsai, W.S., Lin, Y.H. and Tseng, C.Y. (1995) Analysis of clonal relationships among isolates of Shigella sonnei by different molecular typing methods. J Clin Microbiol 33, 1779-1783.
Livermore, D.M. (1987) Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods. Eur J Clin Microbiol 6, 439-445.
Livermore, D.M. (1992) Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 36, 2046-2048.
Lloyd, A.L., Rasko, D.A. and Mobley, H.L. (2007) Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol 189, 3532-3546.
Lomovskaya, O. and Lewis, K. (1992) Emr, an Escherichia coli locus for multidrug resistance. Proc Natl Acad Sci U S A 89, 8938-8942.
Loureiro, I., Frankel, G., Adu-Bobie, J., Dougan, G., Trabulsi, L.R. and Carneiro-Sampaio, M.M. (1998) Human colostrum contains IgA antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins: intimin, BfpA, EspA, and EspB. J Pediatr Gastroenterol Nutr 27, 166-171.
Ma, C. and Chang, G. (2004) Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli. Proc Natl Acad Sci U S A 101, 2852-2857.
Ma, D., Cook, D.N., Alberti, M., Pon, N.G., Nikaido, H. and Hearst, J.E. (1993) Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol 175, 6299-6313.
Ma, D., Cook, D.N., Alberti, M., Pon, N.G., Nikaido, H. and Hearst, J.E. (1995) Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol 16, 45-55.
Ma, L., Siu, L.K., Lin, J.C., Wu, T.L., Fung, C.P., Wang, J.T., Lu, P.L. and Chuang, Y.C. (2013) Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan. BMC Infect Dis 13, 599.
Majiduddin, F.K., Materon, I.C. and Palzkill, T.G. (2002) Molecular analysis of beta-lactamase structure and function. Int J Med Microbiol 292, 127-137.
Mammarappallil, J.G. and Elsinghorst, E.A. (2000) Epithelial cell adherence mediated by the enterotoxigenic Escherichia coli tia protein. Infect Immun 68, 6595-6601.
Mascini, E.M. and Bonten, M.J. (2005) Vancomycin-resistant enterococci: consequences for therapy and infection control. Clin Microbiol Infect 11 Suppl 4, 43-56.
Maurelli, A.T., Fernandez, R.E., Bloch, C.A., Rode, C.K. and Fasano, A. (1998) "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc Natl Acad Sci U S A 95, 3943-3948.
Mendelson, G., Hait, V., Ben-Israel, J., Gronich, D., Granot, E. and Raz, R. (2005) Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 24, 17-22.
Meyer, E., Schwab, F., Schroeren-Boersch, B. and Gastmeier, P. (2010) Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 14, R113.
Michino, H., Araki, K., Minami, S., Takaya, S., Sakai, N., Miyazaki, M., Ono, A. and Yanagawa, H. (1999) Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol 150, 787-796.
Miller, S.I., Ernst, R.K. and Bader, M.W. (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3, 36-46.
Mogre, A., Sengupta, T., Veetil, R.T., Ravi, P. and Seshasayee, A.S. (2014) Genomic analysis reveals distinct concentration-dependent evolutionary trajectories for antibiotic resistance in Escherichia coli. DNA Res 21, 711-726.
Monstein, H.J., Ostholm-Balkhed, A., Nilsson, M.V., Nilsson, M., Dornbusch, K. and Nilsson, L.E. (2007) Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. APMIS 115, 1400-1408.
Moon, H.W., Whipp, S.C., Argenzio, R.A., Levine, M.M. and Giannella, R.A. (1983) Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect Immun 41, 1340-1351.
Morita, Y., Kodama, K., Shiota, S., Mine, T., Kataoka, A., Mizushima, T. and Tsuchiya, T. (1998) NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob Agents Chemother 42, 1778-1782.
Morrissey, I., Hackel, M., Badal, R., Bouchillon, S., Hawser, S. and Biedenbach, D. (2013) A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. Pharmaceuticals (Basel) 6, 1335-1346.
Mudrak, B. and Kuehn, M.J. (2010) Heat-labile enterotoxin: beyond G(m1) binding. Toxins (Basel) 2, 1445-1470.
Munoz, R. and De La Campa, A.G. (1996) ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob Agents Chemother 40, 2252-2257.
Naryshkina, T., Mustaev, A., Darst, S.A. and Severinov, K. (2001) The beta ' subunit of Escherichia coli RNA polymerase is not required for interaction with initiating nucleotide but is necessary for interaction with rifampicin. J Biol Chem 276, 13308-13313.
Nataro, J.P., Hicks, S., Phillips, A.D., Vial, P.A. and Sears, C.L. (1996) T84 cells in culture as a model for enteroaggregative Escherichia coli pathogenesis. Infect Immun 64, 4761-4768.
Nataro, J.P. and Kaper, J.B. (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11, 142-201.
Nataro, J.P., Kaper, J.B., Robins-Browne, R., Prado, V., Vial, P. and Levine, M.M. (1987) Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J 6, 829-831.
Nicolle, L.E. (2005) Catheter-related urinary tract infection. Drugs Aging 22, 627-639.
Nikaido, H. (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67, 593-656.
Nissen, P., Hansen, J., Ban, N., Moore, P.B. and Steitz, T.A. (2000) The structural basis of ribosome activity in peptide bond synthesis. Science 289, 920-930.
Noguera-Obenza, M., Ochoa, T.J., Gomez, H.F., Guerrero, M.L., Herrera-Insua, I., Morrow, A.L., Ruiz-Palacios, G., Pickering, L.K., Guzman, C.A. and Cleary, T.G. (2003) Human milk secretory antibodies against attaching and effacing Escherichia coli antigens. Emerg Infect Dis 9, 545-551.
Ofek, I., Mirelman, D. and Sharon, N. (1977) Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature 265, 623-625.
Olsen, S.J., Miller, G., Breuer, T., Kennedy, M., Higgins, C., Walford, J., McKee, G., Fox, K., Bibb, W. and Mead, P. (2002) A waterborne outbreak of Escherichia coli O157:H7 infections and hemolytic uremic syndrome: implications for rural water systems. Emerg Infect Dis 8, 370-375.
Orskov, F. and Orskov, I. (1992) Escherichia coli serotyping and disease in man and animals. Can J Microbiol 38, 699-704.
Paisley, J.W. and Washington, J.A., 2nd (1978) Synergistic activity of gentamicin with trimethoprim or sulfamethoxazole-trimethoprim against Escherichia coli and Klebsiella pneumoniae. Antimicrob Agents Chemother 14, 656-658.
Park, J.T. and Uehara, T. (2008) How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol Mol Biol Rev 72, 211-227.
Park, Y.S., Yoo, S., Seo, M.R., Kim, J.Y., Cho, Y.K. and Pai, H. (2009) Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae. Int J Antimicrob Agents 34, 38-43.
Patel, A.L., Chaudhry, U., Sachdev, D., Sachdeva, P.N., Bala, M. and Saluja, D. (2011) An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae. Indian J Med Res 134, 419-431.
Paulozzi, L.J., Johnson, K.E., Kamahele, L.M., Clausen, C.R., Riley, L.W. and Helgerson, S.D. (1986) Diarrhea associated with adherent enteropathogenic Escherichia coli in an infant and toddler center, Seattle, Washington. Pediatrics 77, 296-300.
Paulsen, I.T., Brown, M.H., Littlejohn, T.G., Mitchell, B.A. and Skurray, R.A. (1996) Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc Natl Acad Sci U S A 93, 3630-3635.
Peiffer, I., Bernet-Camard, M.F., Rousset, M. and Servin, A.L. (2001) Impairments in enzyme activity and biosynthesis of brush border-associated hydrolases in human intestinal Caco-2/TC7 cells infected by members of the Afa/Dr family of diffusely adhering Escherichia coli. Cell Microbiol 3, 341-357.
Penaranda, M.E., Evans, D.G., Murray, B.E. and Evans, D.J., Jr. (1983) ST:LT:CFA/II plasmids in enterotoxigenic Escherichia coli belonging to serogroups O6, O8, O80, O85, and O139. J Bacteriol 154, 980-983.
Perez-Perez, F.J. and Hanson, N.D. (2002) Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40, 2153-2162.
Peter-Getzlaff, S., Polsfuss, S., Poledica, M., Hombach, M., Giger, J., Bottger, E.C., Zbinden, R. and Bloemberg, G.V. (2011) Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis. J Clin Microbiol 49, 2924-2932.
Philippon, A., Labia, R. and Jacoby, G. (1989) Extended-spectrum beta-lactamases. Antimicrob Agents Chemother 33, 1131-1136.
Pletz, M.W., Rau, M., Bulitta, J., De Roux, A., Burkhardt, O., Kruse, G., Kurowski, M., Nord, C.E. and Lode, H. (2004) Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrob Agents Chemother 48, 3765-3772.
Pluschke, G., Mayden, J., Achtman, M. and Levine, R.P. (1983) Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing. Infect Immun 42, 907-913.
Poirel, L., Heritier, C., Tolun, V. and Nordmann, P. (2004) Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48, 15-22.
Poirel, L., Kampfer, P. and Nordmann, P. (2002) Chromosome-encoded Ambler class A beta-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum beta-lactamases. Antimicrob Agents Chemother 46, 4038-4040.
Poirel, L., Leviandier, C. and Nordmann, P. (2006a) Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital. Antimicrob Agents Chemother 50, 3992-3997.
Poirel, L., Pitout, J.D., Calvo, L., Rodriguez-Martinez, J.M., Church, D. and Nordmann, P. (2006b) In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase. Antimicrob Agents Chemother 50, 1525-1527.
Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B. and Beutler, B. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088.
Poole, K., Krebes, K., McNally, C. and Neshat, S. (1993) Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 175, 7363-7372.
Pultz, M.J. and Donskey, C.J. (2007) Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice. Antimicrob Agents Chemother 51, 3044-3045.
Quinn, J.P., Dudek, E.J., DiVincenzo, C.A., Lucks, D.A. and Lerner, S.A. (1986) Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J Infect Dis 154, 289-294.
Ramirez, M.S. and Tolmasky, M.E. (2010) Aminoglycoside modifying enzymes. Drug Resist Updat 13, 151-171.
Raymond, K.N., Dertz, E.A. and Kim, S.S. (2003) Enterobactin: an archetype for microbial iron transport. Proc Natl Acad Sci U S A 100, 3584-3588.
Razazi, K., Derde, L.P., Verachten, M., Legrand, P., Lesprit, P. and Brun-Buisson, C. (2012) Clinical impact and risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria in the intensive care unit. Intensive Care Med 38, 1769-1778.
Reife, R.A., Shapiro, R.A., Bamber, B.A., Berry, K.K., Mick, G.E. and Darveau, R.P. (1995) Porphyromonas gingivalis lipopolysaccharide is poorly recognized by molecular components of innate host defense in a mouse model of early inflammation. Infect Immun 63, 4686-4694.
Robbins, J.B., McCracken, G.H., Jr., Gotschlich, E.C., Orskov, F., Orskov, I. and Hanson, L.A. (1974) Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med 290, 1216-1220.
Robins-Browne, R.M., Bordun, A.M., Tauschek, M., Bennett-Wood, V.R., Russell, J., Oppedisano, F., Lister, N.A., Bettelheim, K.A., Fairley, C.K., Sinclair, M.I. and Hellard, M.E. (2004) Escherichia coli and community-acquired gastroenteritis, Melbourne, Australia. Emerg Infect Dis 10, 1797-1805.
Rodriguez-Bano, J., Navarro, M.D., Romero, L., Muniain, M.A., Cueto, M., Galvez, J., Perea, E.J. and Pascual, A. (2008) Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clin Microbiol Infect 14, 180-183.
Rodriguez-Bano, J., Navarro, M.D., Romero, L., Muniain, M.A., de Cueto, M., Rios, M.J., Hernandez, J.R. and Pascual, A. (2006) Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 43, 1407-1414.
Rodriguez-Bano, J., Picon, E., Gijon, P., Hernandez, J.R., Ruiz, M., Pena, C., Almela, M., Almirante, B., Grill, F., Colomina, J., Gimenez, M., Oliver, A., Horcajada, J.P., Navarro, G., Coloma, A., Pascual, A. and Spanish Network for Research in Infectious, D. (2010) Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50, 40-48.
Rogers, B.A., Sidjabat, H.E. and Paterson, D.L. (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66, 1-14.
Roland, S., Ferone, R., Harvey, R.J., Styles, V.L. and Morrison, R.W. (1979) The characteristics and significance of sulfonamides as substrates for Escherichia coli dihydropteroate synthase. J Biol Chem 254, 10337-10345.
Ronald, A. (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113 Suppl 1A, 14S-19S.
Rottier, W.C., Bamberg, Y.R., Dorigo-Zetsma, J.W., van der Linden, P.D., Ammerlaan, H.S. and Bonten, M.J. (2015) Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis. Clin Infect Dis 60, 1622-1630.
Russo, T.A., Moffitt, M.C., Hammer, C.H. and Frank, M.M. (1993) TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity. Infect Immun 61, 3578-3582.
Salvador, E., Wagenlehner, F., Kohler, C.D., Mellmann, A., Hacker, J., Svanborg, C. and Dobrindt, U. (2012) Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun 80, 668-678.
Sandkvist, M. (2001) Biology of type II secretion. Mol Microbiol 40, 271-283.
Sanger, F., Nicklen, S. and Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74, 5463-5467.
Sarff, L.D., McCracken, G.H., Schiffer, M.S., Glode, M.P., Robbins, J.B., Orskov, I. and Orskov, F. (1975) Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet 1, 1099-1104.
Scaletsky, I.C., Fabbricotti, S.H., Carvalho, R.L., Nunes, C.R., Maranhao, H.S., Morais, M.B. and Fagundes-Neto, U. (2002) Diffusely adherent Escherichia coli as a cause of acute diarrhea in young children in Northeast Brazil: a case-control study. J Clin Microbiol 40, 645-648.
Schmidt, H., Kernbach, C. and Karch, H. (1996) Analysis of the EHEC hly operon and its location in the physical map of the large plasmid of enterohaemorrhagic Escherichia coli O157:h7. Microbiology 142 ( Pt 4), 907-914.
Schuldiner, S., Lebendiker, M. and Yerushalmi, H. (1997) EmrE, the smallest ion-coupled transporter, provides a unique paradigm for structure-function studies. J Exp Biol 200, 335-341.
Sefton, A.M. (2002) Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium. Drugs 62, 557-566.
Senerwa, D., Mutanda, L.N., Gathuma, J.M. and Olsvik, O. (1991) Antimicrobial resistance of enteropathogenic Escherichia coli strains from a nosocomial outbreak in Kenya. APMIS 99, 728-734.
Short, E.C. and Kurtz, H.J. (1971) Properties of the Hemolytic Activities of Escherichia coli. Infect Immun 3, 678-687.
Shu, J.C., Chia, J.H., Kuo, A.J., Su, L.H. and Wu, T.L. (2010) A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU. Epidemiol Infect 138, 253-263.
Small, P., Blankenhorn, D., Welty, D., Zinser, E. and Slonczewski, J.L. (1994) Acid and base resistance in Escherichia coli and Shigella flexneri: role of rpoS and growth pH. J Bacteriol 176, 1729-1737.
Smith, Y.C., Rasmussen, S.B., Grande, K.K., Conran, R.M. and O'Brien, A.D. (2008) Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect Immun 76, 2978-2990.
Sougakoff, W., Goussard, S. and Courvalin, P. (1988) The TEM-3 β-lactamase, which hydrolyzes broad-spectrum cephalosporins, is derived from the TEM-2 penicillinase by two amino acid substitutions. FEMS Microbiol Lett 56, 343-348.
Spangler, B.D. (1992) Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 56, 622-647.
Staley, T.E., Jones, E.W. and Corley, L.D. (1969) Attachment and penetration of Escherichia coli into intestinal epithelium of the ileum in newborn pigs. Am J Pathol 56, 371-392.
Stamm, W.E. and Hooton, T.M. (1993) Management of urinary tract infections in adults. N Engl J Med 329, 1328-1334.
Stenutz, R., Weintraub, A. and Widmalm, G. (2006) The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol Rev 30, 382-403.
Stiefel, U., Pultz, N.J. and Donskey, C.J. (2007) Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice. Antimicrob Agents Chemother 51, 372-375.
Strahilevitz, J., Jacoby, G.A., Hooper, D.C. and Robicsek, A. (2009) Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22, 664-689.
Tadesse, D.A., Zhao, S., Tong, E., Ayers, S., Singh, A., Bartholomew, M.J. and McDermott, P.F. (2012) Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002. Emerg Infect Dis 18, 741-749.
Tan, T.Y., Ng, L.S., He, J., Koh, T.H. and Hsu, L.Y. (2009) Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antimicrob Agents Chemother 53, 146-149.
Tande, D., Boisrame-Gastrin, S., Munck, M.R., Hery-Arnaud, G., Gouriou, S., Jallot, N., Nordmann, P. and Naas, T. (2010) Intrafamilial transmission of extended-spectrum-beta-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children. J Antimicrob Chemother 65, 859-865.
Tauschek, M., Gorrell, R.J., Strugnell, R.A. and Robins-Browne, R.M. (2002) Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc Natl Acad Sci U S A 99, 7066-7071.
Tchesnokova, V., Aprikian, P., Kisiela, D., Gowey, S., Korotkova, N., Thomas, W. and Sokurenko, E. (2011) Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli. Infect Immun 79, 3895-3904.
Tennent, J.M., Lyon, B.R., Midgley, M., Jones, I.G., Purewal, A.S. and Skurray, R.A. (1989) Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J Gen Microbiol 135, 1-10.
Tenover, F.C., Arbeit, R.D., Goering, R.V., Mickelsen, P.A., Murray, B.E., Persing, D.H. and Swaminathan, B. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.
Then, R.L. (1982) Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole. Rev Infect Dis 4, 261-269.
Thomas, W.E., Trintchina, E., Forero, M., Vogel, V. and Sokurenko, E.V. (2002) Bacterial adhesion to target cells enhanced by shear force. Cell 109, 913-923.
Thomson, K.S. (2010) Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues. J Clin Microbiol 48, 1019-1025.
Thoren, A., Wolde-Mariam, T., Stintzing, G., Wadstrom, T. and Habte, D. (1980) Antibiotics in the treatment of gastroenteritis caused by enteropathogenic Escherichia coli. J Infect Dis 141, 27-31.
Tieng, V., Le Bouguenec, C., du Merle, L., Bertheau, P., Desreumaux, P., Janin, A., Charron, D. and Toubert, A. (2002) Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci U S A 99, 2977-2982.
Tilden, J., Jr., Young, W., McNamara, A.M., Custer, C., Boesel, B., Lambert-Fair, M.A., Majkowski, J., Vugia, D., Werner, S.B., Hollingsworth, J. and Morris, J.G., Jr. (1996) A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health 86, 1142-1145.
Tomasz, A. (1979) The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria. Annu Rev Microbiol 33, 113-137.
Trieber, C.A. and Taylor, D.E. (2002) Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol 184, 2131-2140.
Tseng, T.T., Gratwick, K.S., Kollman, J., Park, D., Nies, D.H., Goffeau, A. and Saier, M.H., Jr. (1999) The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. J Mol Microbiol Biotechnol 1, 107-125.
Tsui, K., Wong, S.S., Lin, L.C., Tsai, C.R., Chen, L.C. and Huang, C.H. (2012) Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type beta-lactamases. J Microbiol Immunol Infect 45, 193-199.
Vila, J., Vargas, M., Casals, C., Urassa, H., Mshinda, H., Schellemberg, D. and Gascon, J. (1999) Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania. Antimicrob Agents Chemother 43, 3022-3024.
Vollaard, E.J. and Clasener, H.A. (1994) Colonization resistance. Antimicrob Agents Chemother 38, 409-414.
Walsh, T.R., Toleman, M.A., Poirel, L. and Nordmann, P. (2005) Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 18, 306-325.
Wanke, C.A., Gerrior, J., Blais, V., Mayer, H. and Acheson, D. (1998a) Successful treatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus. J Infect Dis 178, 1369-1372.
Wanke, C.A., Mayer, H., Weber, R., Zbinden, R., Watson, D.A. and Acheson, D. (1998b) Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus. J Infect Dis 178, 185-190.
Wendt, C., Lin, D. and von Baum, H. (2005) Risk factors for colonization with third-generation cephalosporin-resistant Enterobacteriaceae. Infection 33, 327-332.
Wener, K.M., Schechner, V., Gold, H.S., Wright, S.B. and Carmeli, Y. (2010) Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob Agents Chemother 54, 2010-2016.
Williams, J.B. (1996) Drug efflux as a mechanism of resistance. Br J Biomed Sci 53, 290-293.
Wirth, T., Falush, D., Lan, R., Colles, F., Mensa, P., Wieler, L.H., Karch, H., Reeves, P.R., Maiden, M.C., Ochman, H. and Achtman, M. (2006) Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60, 1136-1151.
Wolf, M.K. (1997) Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin Microbiol Rev 10, 569-584.
Wolfson, J.S. and Hooper, D.C. (1985) The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother 28, 581-586.
Wong, C.S., Jelacic, S., Habeeb, R.L., Watkins, S.L. and Tarr, P.I. (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342, 1930-1936.
Woodford, N., Fagan, E.J. and Ellington, M.J. (2006) Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother 57, 154-155.
Wu, H., Santoni-Rugiu, E., Ralfkiaer, E., Porse, B.T., Moser, C., Hoiby, N., Borregaard, N. and Cowland, J.B. (2010a) Lipocalin 2 is protective against E. coli pneumonia. Respir Res 11, 96.
Wu, S.X. and Peng, R.Q. (1992) Studies on an outbreak of neonatal diarrhea caused by EPEC 0127:H6 with plasmid analysis restriction analysis and outer membrane protein determination. Acta Paediatr 81, 217-221.
Wu, U.I., Yang, C.S., Chen, W.C., Chen, Y.C. and Chang, S.C. (2010b) Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli. J Microbiol Immunol Infect 43, 310-316.
Yan, J.J., Hsueh, P.R., Lu, J.J., Chang, F.Y., Shyr, J.M., Wan, J.H., Liu, Y.C., Chuang, Y.C., Yang, Y.C., Tsao, S.M., Wu, H.H., Wang, L.S., Lin, T.P., Wu, H.M., Chen, H.M. and Wu, J.J. (2006) Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob Agents Chemother 50, 1861-1864.
Yan, J.J., Ko, W.C., Tsai, S.H., Wu, H.M., Jin, Y.T. and Wu, J.J. (2000) Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol 38, 4320-4325.
Yang, H.Y., Nam, Y.S. and Lee, H.J. (2014) Prevalence of plasmid-mediated quinolone resistance genes among ciprofloxacin-nonsusceptible Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in Korea. Can J Infect Dis Med Microbiol 25, 163-169.
Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K. and Konno, M. (1990) Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol 172, 6942-6949.
Yoshida, T., Fukada, M., Koide, N., Ikeda, H., Sugiyama, T., Kato, Y., Ishikawa, N. and Yokochi, T. (1999) Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis. J Infect Dis 180, 2048-2052.
Zagulski, T., Lipinski, P., Zagulska, A., Broniek, S. and Jarzabek, Z. (1989) Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br J Exp Pathol 70, 697-704.
Zhang, L., Huang, Y., Zhou, Y., Buckley, T. and Wang, H.H. (2013) Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota. Antimicrob Agents Chemother 57, 3659-3666.
Zimmerman, J., Selhub, J. and Rosenberg, I.H. (1987) Competitive inhibition of folate absorption by dihydrofolate reductase inhibitors, trimethoprim and pyrimethamine. Am J Clin Nutr 46, 518-522.
|